MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

As of Dec 08, 2025, Alamar Foods CJSC (6014) is trading at a price of 42.12, with a previous close of 42.62. The stock has fluctuated within a day range of 41.98 to 42.76, while its 52-week range ...

Unlike vaccines, Cidara’s products do not rely on the immune system. Credit: Andy Dean Photography via Shutterstock.com. MSD has agreed to acquire Cidara Therapeutics in a $9.2bn deal, adding a new ...

MSD's booth is seen during an expo in Shanghai in November. [PHOTO/CHINA DAILY] With a long-term commitment to the Chinese market, United States-based global pharmaceutical company MSD plans to ...

Nasdaq Dividend History provides straightforward stock’s historical dividends data. Dividend payout record can be used to gauge the company's long-term performance when analyzing individual stocks.

Learn more about the MS Emerging Markets Debt (MSD: XNYS) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you stay up ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. This work is licensed under a Creative Commons ...